Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Sequential Therapy for Poor Risk Recurrent or Refractory Hodgkin's Disease

NCT00544570 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00544570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00544570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Sequential Therapy for Poor Risk Recurrent or Refractory Hodgkin's Disease
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Completed
Start date
April 30, 1998
Completion date
December 31, 2007
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma